Rapid Review Quiz: Hospital-Acquired Pneumonia

September 15, 2022

Meropenem-vaborbactam is among several FDA- and EMA-approved treatments for HAP and VAP. Others include ceftobiprole, ceftolozane-tazobactam, imipenem-relebactam, and cefiderocol. Iclaprim and aztreonam-avibactam are both promising treatments but currently lack approval from the FDA and EMA. Arbekacin has been shown effective in research from Japan but currently lacks approval.

Learn more about meropenem-vaborbactam.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.